Niazi T, Nabid A, Malagon T, Tisseverasinghe S, et al. Hypofractionated Dose Escalation Radiotherapy for High-risk Prostate Cancer: The Survival Analysis of the Prostate Cancer Study 5, a Groupe de Radio-oncologie Genito-urinaire du Quebec-led Phase 3 Trial. Eur Urol 2024 Sep 12:S0302-2838(24)02574-0. doi: 10.1016/j.eururo.2024.
PMID: 39271420